AOD-9604 Dosing AOD-9604 is administered as a daily subcutaneous injection
In comparison, the effects of tesofensine were not significantly different from placebo and were lower than the effects of D-amphetamine 30 mg on both primary and most secondary measures
What to Expect Most peptides produce gradual, cumulative effects rather than dramatic overnight changes
Injection technique and site selection With your peptide properly reconstituted, administration technique becomes the next critical variable
Copper Peptide protects the skin from oxidative damage by capturing and neutralizing free radicals and reducing the occurrence of oxidative reactions
Nasal DPI Peptides for CNS Therapy/Disease Application The IN delivery of proteins and peptides to the CNS allows for the treatment of neurodegenerative diseases such as AD [103], PD [104,105,106], and multiple sclerosis [107,108], among others